Brewin Dolphin LTD Laboratory Corp Of America Holdings Transaction History

Brewin Dolphin LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Nov 09, 2023	SELL	$120.82 - $174.09 $4,591 - $6,615	-38 Closed	0 $0
Q2 2018 Nov 09, 2023	SELL	$160.33 - $189.41 $3,206 - $3,788	-20 Reduced 34.48%	38 $6.82 Million
Q1 2018 Nov 09, 2023	SELL	$161.53 - $178.11 $646 - $712	-4 Reduced 6.45%	58 $9.38 Million
Q3 2017 Nov 09, 2023	BUY	$149.47 - $160.56 $9,267 - $9,954	62	62 $9.36 Million

1.97M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.1B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

Stay updated on Brewin Dolphin LTD with notifications on news.